SRTA · NASDAQ · Services-Health Services
Services-Health Services company based in New York, Ny.
In the last 90 days, no insider of Strata Critical Medical reported an open-market purchase and 0 open-market sales. Every figure links to its official SEC, House, Senate or USAspending record.
Last closeLast close, Oct 6, 2026
$4.75
Last 12 months
Not enough history
Market value
Not available
Bets against the stock: 4.36M shares sold short, −3.7% vs the previous count, 5.2 days of normal trading to buy them back. FINRA, as of Sep 15, 2026.
Revenue
$72.5M
+60.7% vs the same quarter a year earlier
Free cash flow, last 12 months
−$48.4M
This quarter $3.2M, a year earlier −$5.3M
Net debt
—
Debt —, cash $16.3M, at Jun 30, 2026
Net income, last 12 months
$40.2M
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Aug 4, 2026.
Insiders buying, last 90 days
None
No open-market purchases reported
Insiders selling, last 90 days
None
No open-market sales reported
New federal contracts, 12 months
None
Nothing found for this company
Traded Oct 2 · filed the same day
A Strata Critical Medical insider told the SEC about a plan to sell $517K of Strata Critical Medical shares around Oct 2, 2026. The shares were not acquired as compensation. That is 0.1% of all Strata Critical Medical shares.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.